-
5-[(dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]pyridine
-
ChemBase ID:
1173
-
Molecular Formular:
C23H28N8
-
Molecular Mass:
416.52202
-
Monoisotopic Mass:
416.24369294
-
SMILES and InChIs
SMILES:
n1(nc(nc1CCCC)CCCC)Cc1ccc(nc1)c1c(cccc1)c1n[nH]nn1
Canonical SMILES:
CCCCc1nc(nn1Cc1ccc(nc1)c1ccccc1c1n[nH]nn1)CCCC
InChI:
InChI=1S/C23H28N8/c1-3-5-11-21-25-22(12-6-4-2)31(28-21)16-17-13-14-20(24-15-17)18-9-7-8-10-19(18)23-26-29-30-27-23/h7-10,13-15H,3-6,11-12,16H2,1-2H3,(H,26,27,29,30)
InChIKey:
YONOBYIBNBCDSJ-UHFFFAOYSA-N
-
Cite this record
CBID:1173 http://www.chembase.cn/molecule-1173.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
5-[(dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]pyridine
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
7.3489585
|
H Acceptors
|
6
|
H Donor
|
1
|
LogD (pH = 5.5)
|
5.8739867
|
LogD (pH = 7.4)
|
5.5786757
|
Log P
|
5.89256
|
Molar Refractivity
|
145.4405 cm3
|
Polarizability
|
47.581337 Å3
|
Polar Surface Area
|
98.06 Å2
|
Rotatable Bonds
|
10
|
Lipinski's Rule of Five
|
false
|
Log P
|
4.51
|
LOG S
|
-4.8
|
Solubility (Water)
|
6.67e-03 g/l
|
PROPERTIES
PROPERTIES
Bioassay(PubChem)
DETAILS
DETAILS
DrugBank
DrugBank -
DB01342
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Forasartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. Forasartan competes with angiotensin II for binding at the AT1 receptor subtype. As angiotensin II is a vasoconstrictor which also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decreases in systemic vascular resistance. |
Indication |
For the treatment of hypertension. |
Pharmacology |
Forasartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. By inhibiting angiotensin II receptors, this drug leads to a decrease in sodium reabsorption (which decreases water content of blood) and a decrease in vasoconstriction. Combined, this has the effect of lowering blood pressure. |
Affected Organisms |
• |
Humans and other mammals |
|
|
PATENTS
PATENTS
PubChem Patent
Google Patent